CollPlant developing Type I Recombinant Human Collagen from Transgenic Tobacco Plants
06-May-2008 -
CollPlant Ltd., a biotechnology company specializing in the development and commercialization of novel medical products based on its plant-derived, Type I collagen and other recombinant proteins, announced that they elected Mr. Ronny Barak as Chief Executive Officer and Director of CollPlant. ...
biotechnology
chemistry
medical devices
+1